Retraction: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction
Saved in:
| Main Author: | Frontiers Editorial Office |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Oncology |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1538142/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction
by: Zhihui Wen, et al.
Published: (2022-11-01) -
ELABELA targets the MEK/ERK axis to enhance trophoblast invasion in early-onset preeclampsia
by: Lijing Wang, et al.
Published: (2025-08-01) -
MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signaling.
by: Catherine Evans, et al.
Published: (2013-01-01) -
NCAPD3 contributes to lung cancer progression through modulated lactate-induced histone lactylation and MEK/ERK/LDHA axis
by: Zhibo Chang
Published: (2025-05-01) -
Retraction: ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathway
by: Frontiers Editorial Office
Published: (2025-06-01)